Detection of cancer clones in human gastric adenoma by increased DNA-instability and other biomarkers

European Journal of Histochemistry

Volumn 47, Issue 2, 2003, Pages 111-122

  Sun, A ^a   Noriki, S ^a   Imamura, Y ^a   Fukuda, Masaru ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

bFGF; DFF45; DNA instability; Human gastric adenoma; Ki67; p53

Indexed keywords

ANTIBODY; BASIC FIBROBLAST GROWTH FACTOR; BIOLOGICAL MARKER; CELL NUCLEUS DNA; DNA FRAGMENTATION FACTOR 45; HYDROCHLORIC ACID; KI 67 ANTIGEN; PROTEIN P53; UNCLASSIFIED DRUG;

ADENOMA; ARTICLE; CANCER GRADING; CELL CLONE; DISEASE SEVERITY; DNA DENATURATION; DNA DETERMINATION; DNA INSTABILITY TEST; DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDROLYSIS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; STOMACH ADENOCARCINOMA; STOMACH ADENOMA; STOMACH BIOPSY; STOMACH POLYP; TUMOR BIOPSY;

EID: 0037598587     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/815     Document Type: Article

References (97)

1. Ayhan A, Yasui W, Yokozaki H, Seto M, Ueda R, Tahara E. Loss of heterozygosity at the bcl-2 gene locus and expression of bcl-2 in human gastric and colorectal carcinomas. Jpn J Cancer Res 1994;85:584-91.
2. Azuchi M, Baba H, Imura S, Noriki S, Imamura Y, Fukuda M. Demonstration of biological aggressiveness of bone giant cell tumor by the comparative study of immunohistochemical detection of DNAinstability and cortical bone destruction by CT. Acta Histochem Cytochem 1998;31:401-10.
3. Bearzi I, Ranaldi R, Santinelli A, Mannello B, Mariuzzi GM. Epithelial dysplasia of the gastric mucosa. A morphometric and ploidy pattern study. Pathol Res Pract 1992;188:550-5.
4. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase delta. Nature 1987;326:515-7.
5. Bulten J, Poddighe PJ, Robben JC, Gemmink JH, de Wilde PC, Hanselaar AG. Interphase cytogenetic analysis of cervical intraepithelial neoplasia. Am J Pathol 1998;152:495-503.
6. Carey JB, Hay LJ. Gastric polyps. Gastroenterol 1948;10:102-7.
7. Coma-del-Corral MJ, Carretero-Albinana L, Ojeda-Gimenez C. Depressed adenoma of the stomach. Conceptual review and study of five cases. J Clin Gastroenterol 1991;13:353-7.
8. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-40.
9. Dean RT. A mechanism for accelerated degradation of intracellular proteins after limited damage by free radicals. FEBS Lett 1987;220:278-82.
10. D'Errico A, Garbisa S, Liotta LA, Castronovo V, Stetler-Stevenson WG, Grigioni WF. Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod Pathol 1991;4:239-46.
11. Di Gregorio C, Morandi P, Fante R, De Gaetani C. Gastric dysplasia: a follow-up study. Am J Gastroenterol 1993;88:1714-9.
12. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998;391:43-50.
13. Farinati F, Cardin F, Di Mario F, Valiante F, Naccarato R, ArslanPagnini C, et al. Follow-up in gastric dysplasia patients. Am. J. Surg. Pathol 1989;13:173-4.
14. Farinati F, Rugge M, Valiante F, Baffa R, Di Mario F, Naccarato R. Gastric epithelial dysplasia. Gut 1991;32:457.
15. Farinati F, Rugge M, Di Mario F, Variante F, Baffa R. Early and advanced gastric cancer in the follow-up of moderate and severe gastric dysplasia patients. A prospective study. I.G.G.E.D. Interdisciplinary Group on Gastric Epithelial Dysplasia. Endoscopy 1993;25:261-4.
16. Fenoglio-Preiser C, Carneiro F, Correa P, Guilford P, Lambert R, Megraud F, et al. Gastric carcinoma. In World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Digestive System. Hamilton SR and Aaltonen LA, Eds. IARC Press: Lyon; 2000. p. 37-68.
17. Fertitta AM, Comin U, Terruzzi V, Minori G, Zambelli A, Cannatelli G, et al. Clinical significance of gastric dysplasia: a multicenter followup study. Gastrointestinal Endoscopic Pathology Study group. Endoscopy 1993;25:265-8.
18. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hac 70-p53 complex with an altered half-life. Mol Cell Biol 1988;8:531-9.
19. Folkman J, Klagsbru M. Angiogenic factors. Science 1987;235:442-7.
20. Fujita S. Biology of early gastric carcinoma. Pathol Res Pract 1978; 163:297-309.
21. Fukuda M, Miyoshi N, Hattori T, Sugihara H, Hosokawa Y, Nakanishi K. Different instability of nulear DNA at acid hydrolysis in cancerous and noncancerous cells as revealed by fluorescent staining with acridine orange. Histochemistry 1986;84:556-60.
22. Fukuda M, Noriki S, Imamura Y, Miyoshi N, Kimura S, Koizumi K, et al. Differential immunohistochemical staining of cancerous cells with anti-single-stranded DNA antiserum in ordinary pathological paraffin section after DNA-denaturation by acid hydrolysis. Eur J Histochem 1993;37:309-19.
23. Goldstein NS, Lewin KJ. Gastric epithelial dysplasia and adenoma: Historical review and histological criteria for grading. Hum Pathol 1997;28:127-33.
24. Hatchoh M, Ueda K, Imamura Y, Noriki S, Fukuda M. Qualitative and quantitative changes in nuclear DNA and phenotypic gene expression in human malignant skin tumors during their progression. Eur J Histochem 1992;36:289-302.
25. Hay LJ. Polyps and adenomas of the stomach. Surgery 1953;33:446-67.
26. Hearne CM, Ghosh S, Todd JA. Microsatellites for linkage analysis of genetic traits. Trends Genet 1992;8:288-94.
27. Hirai K, Kumakiri M, Ueda K, Imamura Y, Noriki S, Nishi Y, et al. Clonal evolution and progression of 20-methylcholanthrene-induced squamous cell carcinoma of mouse epidermis as revealed by DNA instability and other malignancy markers. Eur J Histochem 2001; 45:319-32.
28. Hirota T, Ming SC. Early gastric carcinoma. In: Ming SC, Goldman H, Eds. Pathology of the gastrointestinal tract. Philadelphia: Saunders; 1992. p. 570-83.
29. Hollstein M, Sidransky D, Vogelstein B, Haris CC. p53 mutations in human cancers. Science 1991;253:49-53.
30. Hoshi T, Sasano H, Kato K, Yabuki N, Ohara S, Konno R, et al. Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis. Anticancer Res 1998; 18:4347-53.
31. Ishida H, kumakiri M, Ueda K, Lao LM, Yanagihara M, Asamoto K, et al. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease. Eur J Histochem 2001;45:177-90.
32. Iwasa M, Imamura Y, Noriki S, Nishi Y, Kato H, Fukuda M. Immunohistochemical detection of early-stage carcinogenesis of oral leukoplakia by increased DNA-instability and various malignancy markers. Eur J Histochem 2001;45:333-46.
33. Jass JR, Filipe MI. Sulphomucins and precancerous lesions of the human stomach. Histopathology 1980;4:271-9.
34. Jego N, Thomas G, Hamelin R. Short direct repeats flanking deletions and duplicating insertions in p53 gene in human cancers. Oncogene 1993;8:209-13.
35. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-21.
36. Kamiya T, Morishita T, Asakura H, Miura S, Munakata Y, Tsuchiya M. Long-term follow-up study on gastric adenoma and its relation to gastric protruded carcinoma. Cancer 1982;50:2496-503.
37. Kaneko E, Nakamura T, Umeda N, Fujino M, Niwa H. Outcome of gastric carcinoma detected by gastric mass survey in Japan. Gut 1977; 18:626-30.
38. Kasai H, Nishimura S. Hydroxylation of guanine in nucleosides and DNA at the C-8 position by heated glucose and oxygen radical-forming agents. Environ Health Perspect 1986;67:111-6.
39. Kashiwagi K, Watanabe M, Ezaki T, Kanai T, Ishii H, Mukai M, et al. Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis. Br J Cancer 2000;82:1814-8.
40. Khaled A, Imamura Y, Noriki S, Fukuda M. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA instability. Eur J Histochem 2000;44:143-56.
41. Kim JJ, Baek MJ, Kim L, Kim NG, Lee YC, Song SY, et al. Accumulated frameshift mutations at coding nucleotide repeats during the progression of gastric carcinoma with microsatellite instability. Lab Invest 1999;79:1113-20.
42. Kim HS, Woo DK, Bae SI, Kim YI, Kim WH. Microsatellite instability in the adenoma-carcinoma sequence of the stomach. Lab Invest 2000;80:57-64.
43. Lansdown M, Quirke P, Dixon MF, Axon AT, Johnston D. High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. Gut 1990;31:977-83.
44. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
45. Levine RL, Oliver CN, Fulks RM, Stadtman ER. Turnover of bacterial glutamine synthetase: Oxidative inactivation precedes proteolysis. Proc Natl Acad Sci USA 1981 78:2120-4.
46. Lewin KJ, Riddell RH, Weinstein WM. Gastrointestinal pathology and its clinical implications. New York: Igaku-shoin. 1992.
47. Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997;89:175-84.
48. Matozaki T, Sakamoto C, Suzuki T, Matsuda K, Uchida T, Nakano O, et al. P53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells. Cancer Res 1992;52:4335-41.
49. Ming SC, Bajtai A, Correa P, Elster K, Jarvi OH, Munoz N, et al. Gastric dysplasia: significance and pathologic criteria. Cancer 1984;54:1794-801.
50. Miracco C, Spina D, Vindigni C, Filipe MI, Tosi P. Cell proliferation patterns and p53 expression in gastric dysplasia. Int J Cancer 1995;62:149-54.
51. Monaco AP, Castleman B, Roth SI, Welch CE. Adenomatous polyps of the stomach: a clinical and pathological study of 153 cases. Cancer 1962;15:465-7.
52. Morson BC, Sobin LH, Grundmann E, Johansen A, Nagayo T, SerckHanssen A. Precancerous conditions and epithelial dysplasia in the stomach. J Clin Pathol 1980;33:711-21.
53. Nakamura K, Sugano H, Takagi K, Fuchigami A. Histopathological study on early carcinoma of the stomach: Criteria for diagnosis of atypical epithelium. Gann 1966;57:613-20.
54. Nakamura K, Sakaguchi H, Enjoji M. Depressed adenoma of the stomach. Cancer 1988;62:2197-202.
55. Nakatsuru S, Yanagisawa A, Furukawa Y, Ichii S, Kato Y, Nakamura Y, et al. Somatic mutations of the APC gene in precancerous lesion of the stomach. Hum Mol Genet 1993;2:1463-5.
56. Nitta Y, Suzuki K, Kohli Y, Fujiki N, Imamura Y, Noriki S, et al. Early progression stage of malignancy of human colon border-line adenoma as revealed by immunohistochemical demonstration of increased DNA-instability. Eur J Histochem 1993;37:207-18.
57. Noriki S, Imamura Y, Ikeda T, Nakanishi K, Miyoshi N, Kohno M, et al. Multi-organ damage (MOD) induced by cancer cachexia and its pathogenesis. Basic Appl Histochem 1989;33:337-46.
58. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996;84:587-97.
59. Otaki T, Kohli Y, Fujiki N, Imamura Y, Fukuda M. Early progression stage of malignancy as revealed by immunohistochemical demonstration of DNA instability; I, human gastric adenomas. Eur J Histochem 1994;38:281-90.
60. Otamiri T, Sjodahl R. Increased lipid peroxidation in malignant tissues of patients with colorectal cancer. Cancer 1989;64:422-5.
61. Ozercan IH, Bahcecioglu IH, Ozercan MR, Bozlak N, Dogan C, Yekeler H. Proliferating cell nuclear antigen and nuclear organizer region for differential diagnosis of dysplasia and adenocarcinoma in gastric biopsies. Indian J Gastroenterol 2000;19:57-60.
62. Pennisi E. New gene forges link between fragile site and many cancers. Science 1996;272:649.
63. Peskin AV, Shlyahova L. Cell nuclei generate DNA-nicking superoxide radicals. FEBS Lett 1986;194:317-21.
64. Plachta A, Speer FD. Gastric polyps and their relationship to carcinoma of the stomach. Am J Gastroenterol 1957;28:160-75.
65. Rubio CA, Kato Y. DNA profiles in mitotic cells from gastric adenomas. Am J Pathol 1988;130:485-8.
66. Rugge M, Farinati F, Di Mario F, Baffa R, Valiante F, Cardin F. Gastric epithelial dysplasia: A prospective multicenter follow-up study from the interdisciplinary group on gastric epithelial dysplasia. Hum Pathol 1991;22:1002-8.
67. Rugge M, Farinati F, Baffa R, Sonego F, Di Mario F, Leandro G, et al. Gastric epithelial dysplasia in the natural history of gastric cancer: A multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. Gastroenterol 1994;107:1288-96.
68. Russell R. Successful growth of tumours. Nature 1989;339:16-7.
69. Sabol SL, Li R, Lee TY, Abdul-Khalek R. Inhibition of apoptosis-associated DNA fragmentation activity in nonapoptotic cells: the role of DNA fragmentation factor-45 (DFF45/ICAD). Biochem Biophys Res Commun 1998;253:151-8.
70. Sano T, Kobori O, Muto T. Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. Br J Surg 1992;79:241-4.
71. Sanz-Ortega J, Sanz-Esponera J, Caldes T, Gomez de la Concha E, Sobel ME, Merino MJ. LOH at the APC/MCC gene (5Q21) in gastric cancer and preneoplastic lesions. Prognostic implications. Pathol Res Pract 1996;192:1206-10.
72. Saraga EP, Gardiol D, Costa J. Gastric dysplasia: a histological followup study. Am J Surg Pathol 1987;11:788-96.
73. Sasaki H, Suzuki T, Funaki N, Hoshi T, Iwabuchi M, Ohi R, et al. Immunohistochemistry of DNA fragmentation factor in human stomach and colon: its correlation to apoptosis. Anticancer Res 1999;19:5277-82.
74. Sasano H, Date F, Imatani A, Asaki S, Nagura H. Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells. Hum Pathol 1993;24:584-9.
75. Schlemper RJ, Itabashi M, Kato Y, Lewin KJ, Riddell RH, Shimoda T, et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet 1997;349:1725-9.
76. Schlüter C, Duchrow M, Wohlenberg C, Becker MH, Key G, Flad HD, et al. The cell proliferation-associated antigen of antibody Ki-67: A very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Bio 1993;123:513-22.
77. Semba S, Yokozaki H, Yamamoto S, Yasui W, Tahara E. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach. Cancer 1996;77:1620-7.
78. Shiao YH, Rugge M, Correa P, Lehmann HP, Scheer WD. p53 alteration in gastric precancerous lesions. Am J Pathol 1994;144:511-7.
79. Shimada S, Tashima S, Yamaguchi K, Matsuzaki H, Ogawa M. Carcinogenesis of intestinal-type gastric cancer and colorectal cancer is commonly accompanied by expression of brain (fetal)-type glycogen phosphorylase. J Exp Clin Cancer Res 1999;18:111-8.
80. Steinbeck RG. Pathologic mitoses and pathology of mitosis in tumorigenesis. Eur J Histochem 2001;45:311-8.
81. Sugano H, Nakamura K, Takagi K. An atypical epithelium of the stomach. A clinico-pathological entity. Gann Monogr Cancer Res 1971; 11:257-69.
82. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-9.
83. Thompson AD, Shen Y, Holman K, Sutherland GR, Callen DF, Richards RI. Isolation and characterization of (AC)n microsatellite genetic markers from human chromosome 16. Genomics 1992;13:402-8.
84. Tomasulo J. Gastric polyps. Histologic types and their relationship to gastric carcinoma. Cancer 1971;27:1346-55.
85. Tosi P, Baak JP, Luzi P, Miracco C, Lio R, Barbini P. Morphometric distinction of low- and high-grade dysplasias in gastric biopsies. Hum Pathol 1989;20:839-44.
86. Tsujitani S, Furusawa M, Hayashi I. Morphological factors aid in therapeutic decisions concerning gastric adenomas. Hepatogastroenterol 1992;39:56-8.
87. Tsuzuki H, Saito H, Imamura Y, Noriki S, Fukuda M. Early progression stage of malignancy as revealed by immunohistochemical demonstration of DNA instability, II otorhinolaryngeal borderline neoplastic lesions. Eur J Histochem 1994;38:291-302.
88. Van Hemmen JJ, Meuling WJ. Inactivation of biologically active DNA by γ-ray-induced superoxide radicals and their dismutation products singlet molecular oxygen and hydrogen peroxide. Biochem Biophys Acta 1975;402:133-41.
89. Wang J, Chi DS, Karin GB, Sosinski C, Miller LE, Burja I, Thomas E. Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions. Dig Dis Sci 2002;47:107-13.
90. White R, Leppert M, Bishop DT, Barker D, Berkowitz J, Brown C, et al. Construction of linkage maps with DNA markers for human chromosomes. Nature 1985;313:101-5.
91. Wong RL, Katz ME, Ogata K, Tan EM, Cohen S. Inhibition of nuclear DNA synthesis by an autoantibody to proliferating cell nuclear antigen/cyclin. Cell Immunol 1987;110:443-8.
92. Wood CB, Haibib NA, Apostolov K, Thompson A, Barker W, Hershman M, et al. Reduction in the stearic to oleic acid ratio in human malignant liver neoplasms. Eur J Surg Oncol 1988;11:347-8.
93. Wu MS, Shun CT, Wang HP, Sheu JC, Lee WJ, Wang TH, et al. Genetic alterations in gastric cancer: relation to histogical subtypes, tumor stage, and helicobacter pylori infection. Gastroenterol 1997;112:1457-65.
94. Xuan ZX, Ambe K, Enjoji M. Depressed adenoma of the stomach, revisited histologic, histochemical, and immunohistochemical profiles. Cancer 1991;67:2382-9.
95. Yabuki N, Sasano H, Kato K, Ohara S, Toyota T, Nagura H, et al. Immunohistochemical study of DNA topoisomerase II in human gastric disorders. Am J Pathol 1996;149:997-1007.
96. Yokota J, Mori N, Akiyama T, Shimosato Y, Sugimura T, Terada M. Multiple genetic alterations in small-cell lung carcinoma. Princess Takamatsu Symp 1989;20:43-48[abstract].
97. Yokota J, Tsukada Y, Nakajima T, Gotoh M, Shimosato Y, Mori N, et al. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res 1989b;49:3598-601.